veriton pharma, serb, btg specialty pharmaceuticals
Weybridge, Surrey
We supply products to over 25 countries worldwide. Veriton Pharma focuses on the
development of licensed medicines, predominantly for CNS, and unlicensed
medicines for patients with special requirements that licensed products cannot
meet. The company has a portfolio of more than 60 specialised formulations for
treating conditions across a range of therapeutic areas. Veriton Pharma’s
products are supported in the UK by a team of Regional Account Managers who are
able to access the NHS at all critical levels. Similarly, both the MEA and
Australian offices are able to provide experienced sales support within each of
these areas.
